Literature DB >> 3033294

Resistance/susceptibility to lethal Sendai virus infection genetically linked to a mucociliary transport polymorphism.

D G Brownstein.   

Abstract

Linkage was tested between a mucociliary transport polymorphism and resistance/susceptibility to lethal Sendai virus infection in segregant hybrid mice of C57BL/6J and DBA/2J parents. The distribution of paired phenotypes for tracheal mucociliary transport rates and susceptibility to lethal Sendai virus infection in 171 F1 X DBA/2J mice showed strong interaction of the parental phenotypes.

Entities:  

Mesh：

Year:  1987        PMID： 3033294      PMCID： PMC254152          DOI： 10.1128/JVI.61.5.1670-1671.1987

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  10 in total

1.  INTERACTION OF RESPIRATORY EPITHELIUM OF THE CHICK AND NEWCASTLE DISEASE VIRUS.

Authors:  F B BANG; M FOARD
Journal:  Am J Hyg       Date:  1964-05

2.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. III. The effects of cyclophosphamide.

Authors:  G Blandford
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

3.  Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice.

Authors:  D G Brownstein; S Winkler
Journal:  Lab Anim Sci       Date:  1986-04

4.  Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents.

Authors:  J C Parker; M D Whiteman; C B Richter
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. I. The fate of viral antigens.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

6.  Pathogenesis of Sendai virus infection in mice.

Authors:  L H Appell; R M Kovatch; J M Reddecliff; P J Gerone
Journal:  Am J Vet Res       Date:  1971-11       Impact factor: 1.156

7.  Tracheobronchial clearance in twins.

Authors:  P Camner; K Philipson; L Friberg
Journal:  Arch Environ Health       Date:  1972-02

8.  Sendai virus infection in genetically resistant and susceptible mice.

Authors:  D G Brownstein; A L Smith; E A Johnson
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

9.  Genetics of natural resistance to Sendai virus infection in mice.

Authors:  D G Brownstein
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  ENZOOTIC SENDAI VIRUS INFECTIONS IN MOUSE BREEDER COLONIES WITHIN THE UNITED STATES.

Authors:  J C PARKER; R W TENNANT; T G WARD; W P ROWE
Journal:  Science       Date:  1964-11-13       Impact factor: 47.728
  10 in total
  5 in total

1.  Genetic determinants of lung virus titers and resistance to lethal Sendai virus pneumonia.

Authors:  D G Brownstein; S Winkler
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.

Authors:  Alicia Solórzano; Jianqiang Ye; Daniel R Pérez
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

3.  Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.

Authors:  John N Mason; Husni Elbahesh; Charles J Russell
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

4.  Differential antigen burden modulates the gamma interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia.

Authors:  X Y Mo; M Sangster; S Sarawar; C Coleclough; P C Doherty
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Authors:  Crystal W Burke; John N Mason; Sherri L Surman; Bart G Jones; Emilie Dalloneau; Julia L Hurwitz; Charles J Russell
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.